The Breast DCIS Score test provides an individualized assessment for the risk of local recurrence. Performed on a tumor sample after a biopsy or surgery, the test looks at 12 cancer-related genes in your patient’s tumor—giving you information that clinical and pathologic factors alone can’t provide. In fact, the test shows that patients with similar clinical and pathologic features do not necessarily have the same local recurrence risk.2-4
The Breast DCIS Score test results include 2-4:
- An individualized prediction of the 10-year risk of any local recurrence (DCIS or invasive carcinoma) or an invasive local recurrence.
- An established baseline for consideration of absolute benefit from radiation therapy (XRT).
- Quantitative ER and PR single gene expression values.
- A patient-friendly summary page to help explain the results to your patients
Learn more: Oncotype DX Breast DCIS Score